Correspondence 0001477932-25-008872 from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Date: Dec. 9, 2025 · CIK: 0001187953 · Accession: 0001477932-25-008872
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291713
Letter
celz_corresp.htm December 9, 2025 Via Edgar Ms. Jessica Dickerson Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission Washington, D.C. 20549 Re: Creative Medical Technology Holdings, Inc. Registration Statement on Form S-3 Filed November 21, 2025 File No. 333-291713 Request for Acceleration Dear Ms. Dickerson: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Creative Medical Technology Holdings, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m. on Friday, December 12, 2025, or as soon thereafter as practicable. Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter. Sincerely, /s/ Timothy Warbington Timothy Warbington Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm celz_corresp.htm December 9, 2025 Via Edgar Ms. Jessica Dickerson Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission Washington, D.C. 20549 Re: Creative Medical Technology Holdings, Inc. Registration Statement on Form S-3 Filed November 21, 2025 File No. 333-291713 Request for Acceleration Dear Ms. Dickerson: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Creative Medical Technology Holdings, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m. on Friday, December 12, 2025, or as soon thereafter as practicable. Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter. Sincerely, /s/ Timothy Warbington Timothy Warbington Chief Executive Officer